RESEARCH ARTICLE
Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care Susie Hoffman1,2*, Theresa M. Exner1☯, Naomi Lince-Deroche3☯¤a, Cheng-Shiun Leu1,4☯, Jessica L. Phillip5☯¤b, Elizabeth A. Kelvin6☯, Anisha D. Gandhi1☯, Bruce Levin1,4, Dinesh Singh5, Joanne E. Mantell1, Kelly Blanchard7‡, Gita Ramjee5‡
a11111
OPEN ACCESS Citation: Hoffman S, Exner TM, Lince-Deroche N, Leu C-S, Phillip JL, Kelvin EA, et al. (2016) Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care. PLoS ONE 11(10): e0162085. doi:10.1371/journal.pone.0162085 Editor: Graciela Andrei, Katholieke Universiteit Leuven Rega Institute for Medical Research, BELGIUM
1 HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, New York, United States of America, 2 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America, 3 Ibis Reproductive Health, Johannesburg, South Africa, 4 Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York, United States of America, 5 South African Medical Research Council, HIV Prevention Research Unit, Durban, South Africa, 6 Epidemiology & Biostatistics Program, CUNY Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America, 7 Ibis Reproductive Health, Cambridge, Massachusetts, United States of America ☯ These authors contributed equally to this work. ¤a Current address: Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa ¤b Current address: Health Systems Trust, Midrand, South Africa ‡ These authors also contributed equally to this work. * [email protected]
Abstract
Received: January 26, 2016 Accepted: August 17, 2016 Published: October 5, 2016 Copyright: © 2016 Hoffman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability Statement: All relevant data are within the paper and its Supporting Information files. Funding: This research was supported by the National Institute of Mental Health (R01 MH83561 and R01 MH083561-03S1; Principal Investigator: Susie Hoffman, DrPH), and by a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University
Background Timely linkage to care by newly-diagnosed HIV+ individuals remains a significant challenge to achieving UNAIDS 90-90-90 goals. Current World Health Organization (WHO) guidelines recommend initiating anti-retroviral treatment (ART) regardless of CD4+ count, with priority given to those with CD4+
Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care Susie Hoffman1,2*, Theresa M. Exner1☯, Naomi Lince-Deroche3☯¤a, Cheng-Shiun Leu1,4☯, Jessica L. Phillip5☯¤b, Elizabeth A. Kelvin6☯, Anisha D. Gandhi1☯, Bruce Levin1,4, Dinesh Singh5, Joanne E. Mantell1, Kelly Blanchard7‡, Gita Ramjee5‡
a11111
OPEN ACCESS Citation: Hoffman S, Exner TM, Lince-Deroche N, Leu C-S, Phillip JL, Kelvin EA, et al. (2016) Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care. PLoS ONE 11(10): e0162085. doi:10.1371/journal.pone.0162085 Editor: Graciela Andrei, Katholieke Universiteit Leuven Rega Institute for Medical Research, BELGIUM
1 HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, New York, United States of America, 2 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America, 3 Ibis Reproductive Health, Johannesburg, South Africa, 4 Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York, United States of America, 5 South African Medical Research Council, HIV Prevention Research Unit, Durban, South Africa, 6 Epidemiology & Biostatistics Program, CUNY Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America, 7 Ibis Reproductive Health, Cambridge, Massachusetts, United States of America ☯ These authors contributed equally to this work. ¤a Current address: Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa ¤b Current address: Health Systems Trust, Midrand, South Africa ‡ These authors also contributed equally to this work. * [email protected]
Abstract
Received: January 26, 2016 Accepted: August 17, 2016 Published: October 5, 2016 Copyright: © 2016 Hoffman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability Statement: All relevant data are within the paper and its Supporting Information files. Funding: This research was supported by the National Institute of Mental Health (R01 MH83561 and R01 MH083561-03S1; Principal Investigator: Susie Hoffman, DrPH), and by a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University
Background Timely linkage to care by newly-diagnosed HIV+ individuals remains a significant challenge to achieving UNAIDS 90-90-90 goals. Current World Health Organization (WHO) guidelines recommend initiating anti-retroviral treatment (ART) regardless of CD4+ count, with priority given to those with CD4+
